EUVIMEDOpdag EUVIMED
Crossref

Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection

Yanmei Gao, Jingjing Wei, Lu Pu, Shengwei Fu, Xiaochen Xing, Rongrong Zhang, Fan Jin iD

ACS Synthetic Biology · 2023

DOI: 10.1021/acssynbio.2c00655 ↗

At a glance

Journal article in ACS Synthetic Biology, 2023. Written by Yanmei Gao and 6 co-authors. Institution: Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, No. 96, JinZhai Road, Baohe Distric…. Major MEDLINE topics: Pseudomonas Infections. Cited 8 times so far (Crossref); 59 references. Funded by: Ministry of Science and Technology of the People's Republic of China, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pseudomonas aeruginosa (P. aeruginosa) infection has become an intractable problem worldwide due to the decreasing efficacy of the mainstay therapy, antibiotic treatment. Hence, exploring new drugs and therapies to address this issue is crucial. Here, we construct a chimeric pyocin (ChPy) to specifically kill P. aeruginosa and engineer a near-infrared (NIR) light-responsive strain to produce and deliver this drug. Our engineered bacterial strain can continuously produce ChPy in the absence of light and release it to kill P. aeruginosa via remotely and precisely controlled bacterial lysis induced by NIR light. We demonstrate that our engineered bacterial strain is effective in P. aeruginosa-infected wound therapy in the mouse model, as it eradicated PAO1 in mouse wounds and shortened the wound healing time. Our work presents a potentially spatiotemporal and noninvasively controlled therapeutic strategy of engineered bacteria for the targeted treatment of P. aeruginosa infections.

Subjects

MeSH terms (MEDLINE)

Pseudomonas InfectionsMiceAnimalsAnti-Bacterial AgentsPyocinsBacteriaPseudomonas aeruginosa

Author keywords

P. aeruginosa infectionchimeric pyocinengineered bacterianear-infrared (NIR) light

Substances

Anti-Bacterial AgentsPyocins

Authors and institutions

  • Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, No. 96, JinZhai Road, Baohe District, Hefei, Anhui 230026, P. R. China.
  • CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China.
  • Department of Fine Chemical Engineering, Shenzhen Polytechnic, Nanshan District, Shenzhen, Guangdong 518055, China.
  • West China School of Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610065, China.

ORCID profiles: Fan Jin

Funding

  • Ministry of Science and Technology of the People's Republic of China
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Chang'an Captial
  • Shenzhen Engineering Research Center of Therapeutic Synthetic Microbes

Cite

APA

Gao, Y., Wei, J., Pu, L., Fu, S., Xing, X., Zhang, R., & Jin, F. (2023). Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.2c00655

Vancouver

Gao Y, Wei J, Pu L, Fu S, Xing X, Zhang R, et al. Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection. ACS Synthetic Biology. 2023. doi:10.1021/acssynbio.2c00655

BibTeX
@article{Gao2023,
  author = {Gao, Yanmei and Wei, Jingjing and Pu, Lu and Fu, Shengwei and Xing, Xiaochen and Zhang, Rongrong and Jin, Fan},
  title = {Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection},
  journal = {ACS Synthetic Biology},
  year = {2023},
  doi = {10.1021/acssynbio.2c00655}
}
Start for free →